Full name: copine 4 | Alias Symbol: COPN4|CPN4 | ||
Type: protein-coding gene | Cytoband: 3q22.1 | ||
Entrez ID: 131034 | HGNC ID: HGNC:2317 | Ensembl Gene: ENSG00000196353 | OMIM ID: 604208 |
Drug and gene relationship at DGIdb |
Expression of CPNE4:
Dataset | Gene | EntrezID | Probe | Log2FC | Adj.pValue | Expression |
---|---|---|---|---|---|---|
GSE17351 | CPNE4 | 131034 | 228796_at | 0.2859 | 0.4429 | |
GSE26886 | CPNE4 | 131034 | 228796_at | 0.2886 | 0.1095 | |
GSE45670 | CPNE4 | 131034 | 228796_at | -0.0998 | 0.4357 | |
GSE53622 | CPNE4 | 131034 | 70011 | -0.5727 | 0.0019 | |
GSE53624 | CPNE4 | 131034 | 70011 | -0.2695 | 0.0551 | |
GSE63941 | CPNE4 | 131034 | 228796_at | 0.1939 | 0.6504 | |
GSE77861 | CPNE4 | 131034 | 228796_at | -0.1929 | 0.0573 | |
TCGA | CPNE4 | 131034 | RNAseq | -1.6219 | 0.0380 |
Upregulated datasets: 0; Downregulated datasets: 1.
Survival by CPNE4 expression:
Note: Click image to view full size file.
Copy number change of CPNE4:
Dataset | Gene | EntrezID | Gain | Loss | Normal | Detail |
---|---|---|---|---|---|---|
GSE15526 | CPNE4 | 131034 | 16 | 0 | 14 | |
GSE20123 | CPNE4 | 131034 | 16 | 0 | 14 | |
GSE43470 | CPNE4 | 131034 | 21 | 0 | 22 | |
GSE46452 | CPNE4 | 131034 | 15 | 4 | 40 | |
GSE47630 | CPNE4 | 131034 | 18 | 3 | 19 | |
GSE54993 | CPNE4 | 131034 | 2 | 8 | 60 | |
GSE54994 | CPNE4 | 131034 | 32 | 3 | 18 | |
GSE60625 | CPNE4 | 131034 | 0 | 6 | 5 | |
GSE74703 | CPNE4 | 131034 | 18 | 0 | 18 | |
GSE74704 | CPNE4 | 131034 | 12 | 0 | 8 | |
TCGA | CPNE4 | 131034 | 59 | 6 | 31 |
Total number of gains: 209; Total number of losses: 30; Total Number of normals: 249.
Somatic mutations of CPNE4:
Generating mutation plots.
Highly correlated genes for CPNE4:
Showing all 5 correlated genes with mean PCC>0.5.
Gene1 | Gene2 | Mean PCC | Num. Datasets | Num. PCC<0 | Num. PCC>0.5 |
---|---|---|---|---|---|
CPNE4 | RLN2 | 0.642819 | 3 | 0 | 3 |
CPNE4 | RNFT2 | 0.629768 | 3 | 0 | 3 |
CPNE4 | SCARNA2 | 0.615565 | 3 | 0 | 3 |
CPNE4 | ZNF572 | 0.595794 | 3 | 0 | 3 |
CPNE4 | MUC16 | 0.595274 | 4 | 0 | 3 |
For details and further investigation, click here